Brian Englander - Profile and Investment Details

Investor Profile

Brian Englander is a Private Equity Firm, Venture Capital based in Boulder, Colorado, United States with a diverse investment portfolio that includes companies such as HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems, TriVascular, Ceterix Orthopaedics, Omeros, Benvenue Medical, AFT Pharmaceuticals, Outset Medical, Good Start Genetics, BioDelivery Sciences International, Valeritas, Intrinsic Therapeutics, NanoString Technologies, Endoceutics, Harmony Biosciences, GenomeDx Biosciences, Bioniche Pharma Group, Blue Belt Technologies, TearLab Corporation, Exagen, Nevro, Avinger, Strongbridge Biopharma, SOC Telemed, Solta Medical, Corium International, Iroko Pharmaceuticals, Cardiome Pharma, ViewRay, Synergy Pharmaceuticals, Autonomic Technologies, EndoGastric Solutions, US WorldMeds, Biodesix, Silk Road Medical, Tandem Diabetes Care, RainDance Technologies, Earlens Corporation, Hicuity Health, Inc.. Over time, Brian Englander has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Brian Englander is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Women Founded, Medical Testing, Healthcare Services, Women Led, Medical Device, Healthcare, Biotechnology, Big Data Analytics, Health Diagnostics, Medical, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Brian Englander, as their portfolio suggests a familiarity and interest in this area.

Understanding Brian Englander’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.